Global Theranostics Market , Analysis and Forecast to 2031, By Product, By Application, By End User
- Published Date : 2024-04-22
- Pages : 100
- Report Id : 40378
- Categories : Pharmaceutical
This report describes the global market size of Theranostics from 2019 to 2022 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2031 and its expected to grow with a CAGR of 14.9% from 2024 to 2031.
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Theranostics estimated at US $ million in the year 2022, is projected to reach a revised size of US$ million by 2031, growing at a CAGR of 14.9% during the forecast period 2023-2030. North American market for Theranostics is estimated to increase from $million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2024 through 2031.
For geography segment, regional supply, demand, major players, price is presented from 2018 to 2030. This report cover following regions:
North America
Asia-Pacific
Europe
Middle East and Africa
South America
The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For competitor segment, the report include global key players of Theranostics as well as some small players. The information for each competitor include:
Company Profile
Main Business Information
SWOT Analysis
Sales Volume, Revenue, Price and Gross Margin
Market Share
By Product
Diagnostic Imaging
Radiopharmaceuticals
IVD/Biomarker Screenin
Software and Services
In terms of product segmentation, the theranostics market is divided into diagnostic imaging, radiopharmaceuticals, IVD/biomarker screening, and software and services.
As of 2022, the diagnostic imaging segment held the largest market share. This significant share can be attributed to the increasing adoption of advanced instruments that support precise diagnosis, coupled with the availability of systems offering improved sensitivity.
These factors are driving the growth of this segment by enhancing the efficiency and accuracy of diagnostic procedures within the theranostics market.
By Application
Prostate Cancer
Bone Metastasis
Neuroendocrine Tumors
Lymphoma
The theranostics market, categorized by application, includes segments such as prostate cancer, bone metastasis, other cancer types, and other applications.
During the forecast period, the prostate cancer segment is expected to exhibit the highest growth rate.
This growth can be primarily attributed to two key factors: the escalating incidence of prostate cancer and the growing investments and funding dedicated to cancer research and treatment.
These factors collectively contribute to the increased focus on developing theranostic solutions tailored specifically for prostate cancer diagnosis and treatment, thereby driving the growth of this segment within the market.
By End User
Hospitals and Clinics
Diagnostic Laboratories
Others
In 2022, the hospitals and cancer care segment held the largest market share within the global theranostics market.
This dominance is primarily driven by two main factors: the increasing adoption of theranostic treatments within hospitals and cancer care centers, and the growing awareness among healthcare professionals and patients regarding the benefits of these treatments.
This trend is further bolstered by recent approvals of theranostic technologies and the rising adoption of advanced diagnostic imaging systems with enhanced features in hospitals, which collectively support improved patient care and treatment outcomes.
By Company
Abbott Laboratories
Myriad Genetics Inc.
Thermo Fisher Scientific Inc.
Hoffmann La Roche Ltd.
Foundation Medicine Inc.
Illumina Inc.
Beckman Coulter, Inc.
Focus Diagnostics
QIAGEN
Agilent Technologies Inc.
Please ask for sample pages for full companies list
Base Year: 2023
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2031
Any special requirements about this report, please let us know and we can provide custom report.
TABLE OF CONTENTS
Market Taxonomy
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis and Recommendations
1.3. RA Analysis and Recommendations
2. Market Introduction
2.1. Market Definition
3. Market Background
3.1. Parent/Associated Market Overview
3.1.1. TheranosticsMarket Outlook
3.1.2. TheranosticsMarket Overview
3.2. Effect of Covid-19 Impact
3.3. Effect of Russia-Ukraine Impact
3.4. Macro-Economic Overview
3.4.1. GDP Growth
3.4.2. Retail Industry Growth
3.5. Pricing Analysis
3.6. Challenges related to adoption of Theranostics
3.7. Regulations of Theranostics Market
3.8. Forecast Factors: Relevance and Impact
3.9. Market Dynamics
3.9.1. Drivers
3.9.2. Restraints
3.9.3. Opportunity
3.9.4. Trends
3.9.5. SWOT Analysis
4. Market Forecast
4.1. Market Value Projections
4.2. Market Size Projections
4.3. Y-o-Y Projections
4.4. Absolute Opportunity Analysis
5. Global TheranosticsValue Chain Analysis
5.1. TheranosticsValue Chain
5.1.1. List of Raw Material Suppliers
5.1.2. List of TheranosticsManufacturer
5.1.3. List of Segment
6. Global TheranosticsMarket Analysis By Product
6.1. Introduction
6.1.1. Market Value Share Analysis By Product
6.1.2. Y-o-Y Growth Analysis By Product
6.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Product
6.3. Market Attractiveness Analysis By Product
7. Global TheranosticsMarket Analysis By EndUser
7.1. Introduction
7.1.1. Market Value Share Analysis By EndUser
7.1.2. Y-o-Y Growth Analysis By EndUser
7.2. Historical Market Size (USD Mn) Analysis 2018-2022 By EndUser
7.3. Market Attractiveness Analysis By EndUser
8. Market Structure Analysis
8.1. Market Analysis by Tier of Companies
8.1.1. By Large, Medium, and Small
8.2. Market Concentration
8.2.1. By Top 5 and by Top 10
8.3. Production Capacity Share Analysis
8.3.1. By Large, Medium, and Small
8.3.2. By Top 5 and Top 10
8.4. Technology Roadmap
9. Competition Analysis
9.1. Competition Dashboard
9.2. Company Profiles (15 Companies)
9.2.1. Abbott Laboratories
9.2.1.1. Overview
9.2.1.2. Product Portfolio
9.2.1.3. Financial Overview
9.2.2. Myriad Genetics Inc.
9.2.2.1. Overview
9.2.2.2. Product Portfolio
9.2.2.3. Financial Overview
9.2.3. Thermo Fisher Scientific Inc.
9.2.3.1. Overview
9.2.3.2. Product Portfolio
9.2.3.3. Financial Overview
9.2.4. Hoffmann La Roche Ltd.
9.2.4.1. Overview
9.2.4.2. Product Portfolio
9.2.4.3. Financial Overview
9.2.5. Foundation Medicine Inc.
9.2.5.1. Overview
9.2.5.2. Product Portfolio
9.2.5.3. Financial Overview
9.2.6. Illumina Inc.
9.2.6.1. Overview
9.2.6.2. Product Portfolio
9.2.6.3. Financial Overview
9.2.7. Beckman Coulter, Inc.
9.2.7.1. Overview
9.2.7.2. Product Portfolio
9.2.7.3. Financial Overview
9.2.8. Agilent Technologies Inc.
9.2.8.1. Overview
9.2.8.2. Product Portfolio
9.2.8.3. Financial Overview
9.2.9. Focus Diagnostics
9.2.9.1. Overview
9.2.9.2. Product Portfolio
9.2.9.3. Financial Overview
9.2.10. QIAGEN
9.2.10.1. Overview
9.2.10.2. Product Portfolio
9.2.10.3. Financial Overview
9.2.11. COMPANY11
9.2.11.1. Overview
9.2.11.2. Product Portfolio
9.2.11.3. Financial Overview
9.2.12. COMPANY12
9.2.12.1. Overview
9.2.12.2. Product Portfolio
9.2.12.3. Financial Overview
9.2.13. COMPANY13
9.2.13.1. Overview
9.2.13.2. Product Portfolio
9.2.13.3. Financial Overview
9.2.14. COMPANY14
9.2.14.1. Overview
9.2.14.2. Product Portfolio
9.2.14.3. Financial Overview
9.2.15. COMPANY15
9.2.15.1. Overview
9.2.15.2. Product Portfolio
9.2.15.3. Financial Overview
10. Global TheranosticsMarket Analysis By Region
10.1. Introduction
10.1.1. Market Value Share Analysis By Region
10.1.2. Y-o-Y Growth Analysis By Region
10.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Region
10.2.1. North America
10.2.2. Middle East and Africa
10.2.3. South America
10.2.4. Asia-Pacific
10.2.5. Others
10.3. Current Market Size (USD Mn) Forecast 2023-2030 By Region
10.3.1. North America
10.3.2. Middle East and Africa
10.3.3. South America
10.3.4. Asia-Pacific
10.3.5. Others
10.4. Market Attractiveness Analysis By Region
11. North America TheranosticsMarket Analysis
11.1. Introduction
11.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
11.2.1. U.S.
11.2.2. Canada
11.2.3. Mexico
11.2.4. Rest of North America
11.3. Current Market Size (USD Mn) Forecast 2023-2030 By Country
11.3.1. U.S.
11.3.2. Canada
11.3.3. Mexico
11.3.4. Rest of North America
11.4. Historical Market Size (USD Mn) Analysis 2018-2022 By Product
11.5. Current Market Size (USD Mn) Forecast 2023-2030 By Product
11.6. Historical Market Size (USD Mn) Analysis 2018-2022 By EndUser
11.7. Current Market Size (USD Mn) Forecast 2023-2030 By EndUser
12. South America TheranosticsMarket Analysis
12.1. Introduction
12.2. Regional Pricing Analysis
12.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
12.3.1. Brazil
12.3.2. Argentina
12.3.3. Rest of South America
12.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
12.4.1. Brazil
12.4.2. Argentina
12.4.3. Rest of South America
12.5. Historical Market Size (USD Mn) Analysis 2018-2022 By Product
12.6. Current Market Size (USD Mn) Forecast 2023-2030 By Product
12.7. Historical Market Size (USD Mn) Analysis 2018-2022 By EndUser
12.8. Current Market Size (USD Mn) Forecast 2023-2030 By EndUser
13. Europe TheranosticsMarket Analysis
13.1. Introduction
13.2. Regional Pricing Analysis
13.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
13.3.1. Germany
13.3.2. Italy
13.3.3. France
13.3.4. Spain
13.3.5. U.K.
13.3.6. Rest of Europe
13.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
13.4.1. Germany
13.4.2. Italy
13.4.3. France
13.4.4. Spain
13.4.5. U.K.
13.4.6. Rest of Europe
13.5. Historical Market Size (USD Mn) Analysis 2018-2022 By Product
13.6. Current Market Size (USD Mn) Forecast 2023-2030 By Product
13.7. Historical Market Size (USD Mn) Analysis 2018-2022 By EndUser
13.8. Current Market Size (USD Mn) Forecast 2023-2030 By EndUser
14. Middle East and Africa TheranosticsMarket Analysis
14.1. Introduction
14.2. Regional Pricing Analysis
14.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
14.3.1. Saudi Arabia
14.3.2. U.A.E.
14.3.3. South Africa
14.3.4. Turkey
14.3.5. Rest of Middle East and Africa
14.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
14.4.1. Saudi Arabia
14.4.2. U.A.E.
14.4.3. South Africa
14.4.4. Turkey
14.4.5. Rest of Middle East and Africa
15. Asia-Pacific TheranosticsMarket Analysis
15.1. Introduction
15.2. Regional Pricing Analysis
15.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
15.3.1. China
15.3.2. India
15.3.3. Japan
15.3.4. South Korea
15.3.5. Singapore
15.3.6. Australia and New Zealand
15.3.7. Rest of Asia-Pacific
15.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
15.4.1. China
15.4.2. India
15.4.3. Japan
15.4.4. South Korea
15.4.5. Singapore
15.4.6. Australia and New Zealand
15.4.7. Rest of Asia-Pacific
i. Research Methodology
ii. Assumptions & Acronyms
LIST OF FIGURES
Figure 01: Global Theranosticsmarket, BPS Analysis, by Product, 2018(H), 2023(E) & 2030(F)
Figure 02: Global Theranosticsmarket, Y-O-Y Growth, by Product, 2020(A) - 2030(F)
Figure 03: Global TheranosticsMarket Attractiveness Analysis, by Product (2020)
Figure 04: Global Theranosticsmarket, BPS Analysis, by EndUser , 2018(H), 2023(E) & 2030(F)
Figure 05: Global Theranosticsmarket, Y-O-Y Growth, by EndUser , 2018(H) - 2030(F)
Figure 06: Global TheranosticsMarket Attractiveness Analysis, by EndUser
Figure 07: Global TheranosticsMarket, Value Analysis, by Product, 2018(H)-2030(F)
Figure 08: Global TheranosticsMarket, Value Analysis, by EndUser , 2018(H)-2030(F)
Figure 09: Global Theranosticsmarket, BPS Analysis, by Region, 2018(H), 2023(E) & 2030(F)
Figure 10: Global Theranosticsmarket, Y-O-Y Growth, by Region, 2018(H) - 2030(F)
Figure 11: Global TheranosticsMarket Attractiveness Analysis, by Region
Figure 12: North America TheranosticsMarket Value (USD Mn Forecast, 2018 � 2022
Figure 13: North America TheranosticsMarket Value (USD Mn Forecast, 2023 � 2030
Figure 14: South America TheranosticsMarket Value (USD Mn) Forecast, 2018 � 2022
Figure 15: South America TheranosticsMarket Value (USD Mn) Forecast, 2023 � 2030
Figure 16: Europe TheranosticsMarket Value (USD Mn) Forecast, 2018 � 2022
Figure 17: Europe TheranosticsMarket Value (USD Mn) Forecast, 2023 � 2030
Figure 18: Middle East and Africa TheranosticsMarket Value (USD Mn) Forecast, 2018 � 2022
LIST OF TABLES
Table 01: Global TheranosticsMarket Value (USD Mn) Forecast, by Product, 2018(H) � 2030(F)
Table 02: Global TheranosticsMarket Value (USD Mn) Forecast, by EndUser , 2018(H) � 2030(F)
Table 03: Global TheranosticsMarket Value (USD Mn) Forecast, by Country, 2018(H) � 2030(F)
Table 04: North America TheranosticsMarket Value (USD Mn) Forecast, by Country, 2018(H) � 2030(F)
Table 05: North America TheranosticsMarket Value (USD Mn) Forecast, by Product, 2018(H) � 2030(F)
Table 06: North America TheranosticsMarket Value (USD Mn) Forecast, by EndUser , 2018(H) � 2030(F)
Table 07: South America TheranosticsMarket Value (USD Mn) Forecast, by Country, 2018(H) � 2030(F)
Table 08: South America TheranosticsMarket Value (USD Mn) Forecast, by Product, 2018(H) � 2030(F)
Table 09: South America TheranosticsMarket Value (USD Mn) Forecast, by EndUser , 2018(H) � 2030(F)
Table 10: Europe TheranosticsMarket Value (USD Mn) and Forecast, by Country, 2018(H) � 2030(F)
Table 11: Europe TheranosticsMarket Value (USD Mn) Forecast, by Product, 2018(H) � 2030(F)
Table 12: Europe TheranosticsMarket Value (USD Mn) Forecast, by EndUser EndUser, 2018(H) � 2030(F)
Table 13: Middle East and Africa TheranosticsMarket Value (USD Mn) Forecast, by Country, 2018(H) � 2030(F)
Table 14: Middle East and Africa TheranosticsMarket Value (USD Mn) Forecast, by Product, 2018(H) � 2030(F)
Table 15: Middle East and Africa TheranosticsMarket Value (USD Mn) Forecast, by EndUser , 2018(H) � 2030(F)
Table 16: Asia-Pacific TheranosticsMarket Value (USD Mn) Forecast, by Country, 2018(H) � 2030(F)
Table 17: Asia-Pacific TheranosticsMarket Value (USD Mn) Forecast, by Product, 2018(H) � 2030(F)
Table 18: Asia-Pacific TheranosticsMarket Value (USD Mn) Forecast, by EndUser , 2018(H) � 2030(F)
Direct Purchase
Your perfect start with Stats And ResearchWant to customize this report?
This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Avail PDF Sample Reports
You may also be lnterested in..
Stats And Research Copyright © 2024 .